Related Experiment Video
Updated: Jun 4, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Global burden of tuberculous meningitis in children aged 0-14 years in 2019: a mathematical modelling study
Karen du Preez1, Helen E Jenkins2, Leonardo Martinez3
1Desmond Tutu Tuberculosis Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
Insights
An estimated 24,000 children developed tuberculous meningitis in 2019, with over 16,000 deaths. Early diagnosis and treatment are crucial for improving outcomes in childhood tuberculous meningitis.
Area of Science:
- Global health
- Epidemiology
- Infectious diseases
Background:
- Tuberculous meningitis is a severe, often fatal, neurological condition in children.
- Limited data exist on the global burden of childhood tuberculous meningitis.
- Estimating disease burden is critical for public health interventions.
Purpose of the Study:
- To estimate the global disease burden and mortality of childhood tuberculous meningitis in 2019.
- To analyze these estimates by WHO regions, age groups, treatment status, and HIV status.
- To provide data for informing public health strategies and resource allocation.
Main Methods:
- A Bayesian mathematical model was developed to estimate cases, deaths, and sequelae.
- Literature reviews and meta-analyses quantified key parameters, including infection risk and case-fatality rates.
- Utilized tuberculosis surveillance data from various countries and aggregated regional data.
Main Results:
- An estimated 24,000 children (0-14 years) developed tuberculous meningitis in 2019.
- Approximately 16,100 deaths were attributed to tuberculous meningitis, with most occurring in children under 5 and those untreated.
- Over 5,500 survivors experienced neurological sequelae.
Conclusions:
- Childhood tuberculous meningitis represents a significant global health challenge with high mortality and morbidity.
- Improved diagnostics and robust healthcare systems are essential for early detection and better outcomes.
- Tuberculosis prevention strategies must be prioritized as a public health imperative.
Background:
Tuberculous meningitis is fatal if untreated and can lead to lifelong neurological sequelae. However, to our knowledge, there are no data on the number of children affected by this disease. We aimed to estimate the global disease burden and attributable mortality of childhood tuberculous meningitis by WHO regions, age groups, treatment status, and HIV status in 2019.
Methods:
We developed a Bayesian mathematical model to estimate the number of children aged 0-14 years who developed tuberculous meningitis, died from tuberculous meningitis, and did not die from tuberculous meningitis but had neurological sequelae in 2019. We reviewed the literature and used meta-analyses to quantify key parameters used as model inputs: risk of tuberculous meningitis after Mycobacterium tuberculosis infection, tuberculous meningitis as a proportion of tuberculosis notification data (ie, routine surveillance data that countries report to WHO), and risk ratios for tuberculous-meningitis mortality by age group. We identified routine tuberculosis surveillance data from countries and literature that reported the proportion of notified childhood tuberculosis that was due to tuberculous meningitis. Country-level data were from Brazil; the USA; Ukraine; South Africa; and the European Centre for Disease Prevention and Control, which included 29 countries but was aggregated and considered as one site. We assumed tuberculosis notification was synonymous with detection and treatment, combined age-disaggregated risk ratios and published meta-analytic estimates of the case-fatality rate in children who received treatment to produce estimates of tuberculous-meningitis mortality by age group and HIV status, and assumed that untreated tuberculous meningitis was always fatal. We assumed similar age-disaggregated risk ratios for neurological sequelae among children who had treatment for tuberculous meningitis and lived as for children who died.
Findings:
An estimated 24 000 (95% credible interval 22 300-25 700) children younger than 15 years developed tuberculous meningitis in 2019. Of these children, 13 000 (12 100-13 900) were estimated to have been diagnosed and treated for tuberculous meningitis. Most untreated children were younger than 5 years. Among the 24 000 children with tuberculous meningitis, 16 100 (14 900-17 300) were estimated to have died in 2019, of whom 1101 (6·8%) had HIV. 13 380 (83·1%) of 16 100 deaths were estimated to be in children younger than 5 years and 11 000 (68·3%) were estimated to be in children who did not receive tuberculous-meningitis treatment. Of the 7900 (5800-10 000) children who did not die, 5550 (5110-5980) were estimated to have neurological sequelae.
Interpretation:
Our estimates of tuberculous meningitis in children younger than 15 years showed substantial mortality and morbidity. Improved diagnostics and strong health-care systems to facilitate early diagnosis are crucial to improve outcomes, and tuberculosis prevention should be a public health priority.
Funding:
Fogarty International Center of the US National Institutes of Health.
More Related Videos
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
09:23Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
Published on: June 30, 2019
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Probability Laws